SEEGENE, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22,350 KRW | +0.90% |
|
+2.05% | -2.40% |
| 14/03 | Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 24/01 | Seegene Inc. Announces Collaboration with Microsoft to Realize a World Free from All Diseases | CI |
Chart calendar Seegene, Inc.
b974f569632176be81417bb.1u1fUj_cGCZDCbvFwB_hYPhZxo8NcKJkv7zPOE_onFw.rIhrGFu0WkI3WcyalFKuGaIdjr08Cusj286GCSSwymSgvxYDaO50QAU_9g~4431a7af94cfd7bcd02c9c8491281f29
Upcoming events on Seegene, Inc.
Past events on Seegene, Inc.
| 16/02/2024 | Q4 2023 Earnings Release |
| 10/11/2023 | Q3 2023 Earnings Release |
| 11/08/2023 | Q2 2023 Earnings Release |
| 14/07/2023 12:30 pm | Investor Meeting |
| 12/07/2023 10:30 am | Investor Meeting |
| 15/05/2023 | Q1 2023 Earnings Release |
| 16/03/2023 | Q4 2022 Earnings Release |
| 14/11/2022 | Q3 2022 Earnings Release |
| 12/08/2022 04:30 pm | Interim 2022 Earnings Release |
| 26/07/2022 | American Association of Clinical Chemistry Scientific Meeting |
| 16/05/2022 | Q1 2022 Earnings Release |
| 17/02/2022 | FY 2021 Earnings Release |
| 26/09/2021 | AACC Scientific Meeting & Clinical Lab Expo |
| 17/08/2021 | Interim 2021 Earnings Release |
| 12/05/2021 06:48 am | Q1 2021 Earnings Release |
| 18/02/2021 | FY 2020 Earnings Release |
| 16/02/2021 | International Molecular Medicine Tri-Conference |
| 30/03/2020 | FY 2019 Earnings Release |
| 14/11/2019 | Q3 2019 Earnings Release |
| 15/05/2019 | Q1 2019 Earnings Release |
Past dividends on Seegene, Inc.
| 28/03/2024 | Interim Payment 200 KRW |
| 27/12/2023 | Final Payment 200 KRW |
| 26/09/2023 | Interim Payment 200 KRW |
| 29/06/2023 | Interim Payment 200 KRW |
| 30/03/2023 | Interim Payment 200 KRW |
| 28/12/2022 | Final Payment 200 KRW |
| 29/09/2022 | Interim Payment 200 KRW |
| 29/06/2022 | Interim Payment 200 KRW |
| 30/03/2022 | Interim Payment 200 KRW |
| 29/12/2021 | Final Payment 400 KRW |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Billions KRW | Released Forecast Spread | 122 123 -0.65% | 1 125 1 069 5.25% | 1 370 1 387 -1.2% | 853 882 -3.2% | 367 354 3.69% | 397 |
|
EBITDA Billions KRW | Released Forecast Spread | 31,2 33,1 -5.75% | 693 694 -0.12% | 703 704 -0.17% | 254 250 1.86% | 0,00 30,0 - | 0,00 |
|
EBIT Billions KRW | Released Forecast Spread | 22,4 24,0 -6.61% | 676 667 1.36% | 667 677 -1.55% | 196 213 -8.12% | 0,00 -29,6 - | 12,2 |
|
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 27,7 28,5 -2.62% | 669 678 -1.31% | 689 706 -2.38% | 226 265 -14.83% | 0,00 -1,00 - | 0,00 |
|
Net income Billions KRW | Released Forecast Spread | 26,7 25,2 6.05% | 502 524 -4.22% | 537 539 -0.45% | 182 209 -12.8% | 0,45 -1,00 144.8% | 17,2 |
|
EPS KRW | Released Forecast Spread | 513 462 11.16% | 9 662 9 991 -3.3% | 10 359 10 333 0.26% | 3 586 3 998 -10.31% | 14,0 -18,0 177.78% | 330 |
| Announcement Date | 26/02/20 | 18/02/21 | 17/02/22 | 17/02/23 | 16/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Billions KRW | Released Forecast Spread | 410 426 -3.71% | 452 419 7.87% | 128 265 -51.49% | 151 136 11.13% | 123 144 -14.52% | 90,0 126 -28.53% | 84,9 86,5 -1.82% | 91,9 85,4 7.59% | 101 93,9 7.04% | 95,9 | 94,2 | 102 | 109 |
|
EBIT Billions KRW | Released Forecast Spread | 200 211 -5.02% | 200 212 -5.8% | 13,0 106 -87.75% | -32,2 24,9 -229.32% | 15,5 35,5 -56.3% | -13,8 30,0 -145.91% | -9,66 -0,50 -1832.6% | -10,1 -6,10 -65.48% | 3,48 -0,10 3577% | 0,10 | 0,90 | 3,30 | 7,90 |
|
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 196 213 -7.81% | 217 212 2.59% | 27,2 106 -74.38% | -18,3 20,5 -189.35% | -0,37 30,3 -101.23% | ||||||||
|
Net income Billions KRW | Released Forecast Spread | 164 167 -1.84% | 165 177 -6.25% | 25,2 84,0 -70.06% | -11,1 19,9 -155.53% | 2,59 31,3 -91.74% | 2,05 12,0 -82.9% | -2,54 1,10 -330.91% | -4,68 -2,30 -103.35% | 5,61 1,80 211.78% | 2,20 | 2,50 | 4,30 | 8,20 |
| Announcement Date | 17/02/22 | 13/05/22 | 12/08/22 | 11/11/22 | 17/02/23 | 15/05/23 | 11/08/23 | 10/11/23 | 16/02/24 | - | - | - | - |
| 08/05/2024 01:35 am | VERACYTE, INC.: Q1 2024 Earnings Release |
| 09/05/2024 01:35 am | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 01:35 am | EXACT SCIENCES CORPORATION: Q1 2024 Earnings Release |
| 10/05/2024 01:31 am | IOVANCE BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | GUARDANT HEALTH, INC.: Q1 2024 Earnings Release |
| 13/05/2024 | SEEGENE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/07/2024 | VERACYTE, INC.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | EXACT SCIENCES CORPORATION: Q2 2024 Earnings Release (Projected) |
| 31/07/2024 | ADAPTIVE BIOTECHNOLOGIES CORPORATION: Q2 2024 Earnings Release (Projected) |
| 01/08/2024 | CAREDX, INC: Q2 2024 Earnings Release (Projected) |
Past sector events for Seegene, Inc.
| 27/04/2024 | BGI GENOMICS CO., LTD.: Q1 2024 Earnings Release |
| 13/04/2024 | BGI GENOMICS CO., LTD.: Q4 2023 Earnings Release |
| 29/02/2024 02:35 am | CAREDX, INC: Q4 2023 Earnings Release |
| 29/02/2024 02:31 am | IOVANCE BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release |
| 23/02/2024 02:35 am | VERACYTE, INC.: Q4 2023 Earnings Release |
| 23/02/2024 02:35 am | GUARDANT HEALTH, INC.: Q4 2023 Earnings Release |
| 23/02/2024 02:35 am | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q4 2023 Earnings Release |
| 22/02/2024 02:35 am | EXACT SCIENCES CORPORATION: Q4 2023 Earnings Release |
| 16/02/2024 | SEEGENE, INC.: Q4 2023 Earnings Release |
| 10/11/2023 | SEEGENE, INC.: Q3 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A096530 Stock
- Calendar Seegene, Inc.
